AU7128494A - Gelatinase antagonists used for treating cancer - Google Patents

Gelatinase antagonists used for treating cancer

Info

Publication number
AU7128494A
AU7128494A AU71284/94A AU7128494A AU7128494A AU 7128494 A AU7128494 A AU 7128494A AU 71284/94 A AU71284/94 A AU 71284/94A AU 7128494 A AU7128494 A AU 7128494A AU 7128494 A AU7128494 A AU 7128494A
Authority
AU
Australia
Prior art keywords
gelatinase
treating cancer
antagonists used
antagonists
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU71284/94A
Inventor
Terence Seward Baker
Thomas Crabbe
Andrew James Penrose Docherty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCB Celltech Ltd
Original Assignee
Celltech R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939314336A external-priority patent/GB9314336D0/en
Priority claimed from GB939322774A external-priority patent/GB9322774D0/en
Application filed by Celltech R&D Ltd filed Critical Celltech R&D Ltd
Publication of AU7128494A publication Critical patent/AU7128494A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6489—Metalloendopeptidases (3.4.24)
    • C12N9/6491—Matrix metalloproteases [MMP's], e.g. interstitial collagenase (3.4.24.7); Stromelysins (3.4.24.17; 3.2.1.22); Matrilysin (3.4.24.23)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AU71284/94A 1993-07-09 1994-07-08 Gelatinase antagonists used for treating cancer Abandoned AU7128494A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB939314336A GB9314336D0 (en) 1993-07-09 1993-07-09 Mutant metalloproteinases
GB9314336 1993-07-09
GB939322774A GB9322774D0 (en) 1993-11-04 1993-11-04 Mutant metalloproteinases
GB9322774 1993-11-04
PCT/GB1994/001485 WO1995002045A2 (en) 1993-07-09 1994-07-08 Gelatinase antagonists used for treating cancer

Publications (1)

Publication Number Publication Date
AU7128494A true AU7128494A (en) 1995-02-06

Family

ID=26303228

Family Applications (1)

Application Number Title Priority Date Filing Date
AU71284/94A Abandoned AU7128494A (en) 1993-07-09 1994-07-08 Gelatinase antagonists used for treating cancer

Country Status (2)

Country Link
AU (1) AU7128494A (en)
WO (1) WO1995002045A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0733369A1 (en) * 1995-03-23 1996-09-25 Stichting REGA V.Z.W. Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors
EP0736302A3 (en) * 1995-03-23 1997-06-04 Stichting Rega V Z W Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors
AU2001240820A1 (en) * 2000-03-15 2001-09-24 Oxford Glycosciences (Uk) Ltd. Proteins, genes and their use for diagnosis and treatment of vascular dementia
US7071164B2 (en) 2001-08-16 2006-07-04 Kimberly-Clark Worldwide, Inc. Anti-cancer and wound healing compounds
US6906036B2 (en) * 2001-08-16 2005-06-14 Kimberly-Clark Worldwide, Inc. Anti-aging and wound healing compounds
US7186693B2 (en) 2001-08-16 2007-03-06 Kimberly - Clark Worldwide, Inc. Metalloproteinase inhibitors for wound healing
US7148194B2 (en) 2002-12-30 2006-12-12 Kimberly-Clark Worldwide, Inc. Method to increase fibronectin
US7189700B2 (en) 2003-06-20 2007-03-13 Kimberly-Clark Worldwide, Inc. Anti-chrondrosarcoma compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4625014A (en) * 1984-07-10 1986-11-25 Dana-Farber Cancer Institute, Inc. Cell-delivery agent
GB2209526B (en) * 1987-09-04 1992-06-03 Univ Washington Dna clone of human type iv collagenase
JP2625156B2 (en) * 1988-06-24 1997-07-02 市郎 東 Polypeptide consisting of repeating structure of cell adhesion active core sequence

Also Published As

Publication number Publication date
WO1995002045A2 (en) 1995-01-19
WO1995002045A3 (en) 1995-05-19

Similar Documents

Publication Publication Date Title
AU5975694A (en) Electrotherapeutic apparatus
AU7779694A (en) Antenna apparatus
AU1072695A (en) Dressing
AU7874094A (en) Retrievable, shielded radiotherapy implant
AU7479594A (en) Chuck
AU7479694A (en) Chuck
GB9315595D0 (en) New compounds
AU6623894A (en) Therapeutic compounds
AU1272295A (en) Proinsulin-like compounds
AU5389194A (en) Wastewater treatment
ZA945545B (en) Psoriasis treatment
AU7961094A (en) Picosulphate dosage form
AU6076994A (en) Grinding apparatus
AU2500192A (en) Cholecystokinin antagonists useful for treating depression
AU6092794A (en) Oxime-substituted therapeutic compounds
GB9315846D0 (en) Tumour inhibitors
AU7963394A (en) Mercaptosulfide metalloproteinase inhibitors
AU6253094A (en) Methods for the treatment of osteoporosis
EP0671159A4 (en) Self-tanning cosmetic.
AU5261093A (en) Aminoalkylphenyl compounds
AU7822591A (en) Treating an underground formation
AU1480497A (en) Cancer treatment
AU1278295A (en) Wastewater treatment
AU7128494A (en) Gelatinase antagonists used for treating cancer
AU7018794A (en) Methods for treating pathologies